| Jeffrey Hamilton Pruitt, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 645-0624 | |
| (214) 645-0078 |
| Full Name | Jeffrey Hamilton Pruitt |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407811219 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | K4198 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkland Health & Hospital System | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
BioLineRx a biopharmaceutical development company, announced today that it has received approval from the Israeli Ministry of Health for commencing a Phase II clinical trial of BL-7040, an orally available molecule for treating Inflammatory Bowel Disease (IBD).
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge.
› Verified 1 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
BioLineRx a biopharmaceutical development company, announced today that it has received approval from the Israeli Ministry of Health for commencing a Phase II clinical trial of BL-7040, an orally available molecule for treating Inflammatory Bowel Disease (IBD).
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Hamilton Pruitt, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 645-0624 | Jeffrey Hamilton Pruitt, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 645-0624 |
News Archive
BioLineRx a biopharmaceutical development company, announced today that it has received approval from the Israeli Ministry of Health for commencing a Phase II clinical trial of BL-7040, an orally available molecule for treating Inflammatory Bowel Disease (IBD).
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge.
› Verified 1 days ago
Dr. Nhat-long Lam Pham, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 Forest Park Rd, Dallas, TX 75390 Phone: 241-645-7615 Fax: 214-645-7624 | |
Firouzeh Arjmandi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Dallas, TX 75390 Phone: 214-645-3586 | |
Dr. John Debevits Iv, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3928 | |
Natalia Cabrera Almonte, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd # E6112, Dallas, TX 75390 Phone: 214-648-2054 | |
W Crysup Sory, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 12700 Park Central Dr, Ste 430, Dallas, TX 75251 Phone: 972-239-8902 Fax: 972-661-2551 | |
Jacqueline Tyra Caire, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 469-757-1000 | |
Dr. Thomas Louis Borok, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5004 Spyglass Drive, Dallas, TX 75287 Phone: 972-931-1073 Fax: 972-931-1073 |